| Updated:
3i in earnings boost as client funds rise
London-listed private equity firm 3i Group said its deal pipeline is picking up as financing conditions improve and trading stabilises, helping boost earnings at its own portfolio companies.
Investments over the three months to end totalled £105m, including a £35m investment in French healthcare company Vedici.
Proceeds from company sales were £79m, down from £163m in 2009, but do not include the recently agreed sale of the commodities testing and inspection arm of Inspicio for £450m.
The group valued its portfolio at 321 pence a share at the end of March, up 15 per cent on the year.